Craig R. Skenes
Corporate Officer/Principal en AERIE PHARMACEUTICALS, INC. .
Perfil
Craig R.
Skenes is currently the Vice President of Business Development at Aerie Pharmaceuticals, Inc. He received his undergraduate degree and MBA from The California State University.
Cargos activos de Craig R. Skenes
Empresas | Cargo | Inicio |
---|---|---|
AERIE PHARMACEUTICALS, INC. | Corporate Officer/Principal | 16/06/2014 |
Formación de Craig R. Skenes.
The California State University | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 1 |
---|---|
Aerie Pharmaceuticals, Inc.
Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on January 1, 2005 and is headquartered in Durham, NCForth Worth, TX. | Health Technology |
- Bolsa de valores
- Insiders
- Craig R. Skenes